In a filing, Incyte Corp revealed its Officer VIJAY IYENGAR acquired Company’s shares for reported $1.69 million on Jan 05 ’26. In the deal valued at $102.81 per share,16,437 shares were bought.
Then, STEVEN STEIN bought 15,634 shares, generating $1,589,995 in total proceeds.
Before that, Tray Thomas sold 2,774 shares. Incyte Corp shares valued at $277,400 were divested by the Principal Accounting Officer at a price of $100.00 per share. As a result of the transaction, Tray Thomas now holds 22,973 shares, worth roughly $2.34 million.
Mizuho upgraded its Incyte Corp [INCY] rating to an Outperform from a a Neutral in a research note published recently. A number of analysts have revised their coverage, including Guggenheim’s analysts, who increased its forecast for the stock in early November from “a Neutral” to “a Buy”. Oppenheimer also remained covering INCY and has decreased its forecast on October 08, 2025 with a “Perform” recommendation from previously “an Outperform” rating. Wells Fargo revised its rating on August 06, 2025. It rated INCY as “an Overweight” which previously was an “an Equal weight”.
Price Performance Review of INCY
On Monday, Incyte Corp [NASDAQ:INCY] saw its stock jump 0.36% to $101.79. Over the last five days, the stock has gained 1.68%. Incyte Corp shares have risen nearly 47.37% since the year began. Nevertheless, the stocks have risen 3.06% over the past one year. While a 52-week high of $109.28 was reached on 01/05/26, a 52-week low of $53.56 was recorded on 01/02/26.
Levels Of Support And Resistance For INCY Stock
The 24-hour chart illustrates a support level at 99.55, which if violated will result in even more drops to 97.31. On the upside, there is a resistance level at 103.52. A further resistance level may holdings at 105.25.
How much short interest is there in Incyte Corp?
A steep rise in short interest was recorded in Incyte Corp stocks on 2025-12-15, growing by 1.26 million shares to a total of 10.75 million shares. Yahoo Finance data shows the prior-month short interest on 2025-11-14 was 9.5 million shares. There was a rise of 11.71%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on August 01, 2025 when Barclays began covering the stock and recommended ‘”an Overweight”‘ rating along with a $90 price target.
